Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 7, 2014 - Issue
Submit an article Journal homepage
101
Views
3
CrossRef citations to date
0
Altmetric
Review

Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma

Tanya SiddiqiCity of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA, USA
,
Sandra H ThomasCity of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA, USA
&
Robert ChenCity of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA, USACorrespondence[email protected]
Pages 79-85 | Published online: 20 Feb 2014

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Brynn N. Wajda & Michael P. Rabinowitz. (2017) A rare case of orbital hodgkin lymphoma demonstrating therapeutic response to a novel systemic medication. Orbit 36:1, pages 52-54.
Read now
Anh Pham & Robert Chen. (2015) Brentuximab vedotin for the treatment of Hodgkin’s lymphoma. Expert Review of Hematology 8:4, pages 403-412.
Read now

Articles from other publishers (1)

Mei Guan, Yan-Ping Zhou, Jin-Lu Sun & Shu-Chang Chen. (2015) Adverse Events of Monoclonal Antibodies Used for Cancer Therapy. BioMed Research International 2015, pages 1-13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.